clarithromycin has been researched along with cefuroxime in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (38.30) | 18.2507 |
2000's | 18 (38.30) | 29.6817 |
2010's | 9 (19.15) | 24.3611 |
2020's | 2 (4.26) | 2.80 |
Authors | Studies |
---|---|
Dhoore, F; Verbist, L | 1 |
Dalhoff, K; Maass, M | 1 |
Parent, M | 1 |
Rodriguez, WJ; Wiedermann, BL | 1 |
Bagarazzi, ML; Hogarty, M; Kim, IK; McGowan, KL; Watson, B | 1 |
Conte, JE; Duncan, S; Golden, J; Lin, E; McKenna, E; Zurlinden, E | 1 |
Carpentier, M; Delmée, M; Glupczynski, Y; Gordts, B; Magerman, K; Simon, A; Surmont, I; Van de Vyvere, M; Van Landuyt, H; Van Nimmen, L; Van Noyen, R | 1 |
Bermejo, M; García-de-Lomas, J; García-Ponte, L; Garijo, B; Gimeno, C; Lázaro, MA; Millás, E; Navarro, D | 1 |
Brookings, E; Gray, B; Swiatlo, E; Waites, K | 1 |
Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W | 1 |
Amougou, M; Fossion, M; Mengeot, PM; Vandeven, J; Verbiest, N; Verbist, L; Verhaegen, J | 1 |
Kahn, J; Mauriz, Y; Ogilvie, P; Thornsberry, C | 1 |
Barg, N | 1 |
Lacy, MK; Nicolau, DP; Nightingale, CH; Owens, RC; Quintiliani, R; Xu, X | 1 |
Jablonicky, P; Jacovides, A; Sedani, S; Staley, H; Stefansson, P | 1 |
Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G | 1 |
Anzueto, A; Grossman, RF; Rizzo, JA | 1 |
Belda, A; Gonzalvo, F; Martínez-Moragón, E; Pascual, JM; Ripollés, F; Rovira, E | 1 |
Al Rasheed, AM; Elbashier, AM; Osoba, AO; Shibl, AM | 1 |
Weiss, LR | 1 |
Allegra, L; Huchon, G; Izquierdo, JL; Jones, P; Sagnier, PP; Schaberg, T; Wilson, R | 1 |
Aurangzeb, B; Hameed, A | 1 |
Klatka, J; Obszańska, B; Polberg, K; Remer, M | 1 |
Albrecht, JE; Gair, RD; Glezos, JD | 1 |
Falguera, M; Giménez, A; Gómez-Arbonés, X; Porcel, JM; Ruiz-González, A; Sánchez, V; Soler-González, J | 1 |
Altraja, A; Kullamaa, A; Leesik, H; Meriste, S; Naaber, P; Tamm, E | 1 |
Decramer, M; Martin, M; Moore, L; Quilici, S; Simoens, S | 1 |
Larkin, JM | 1 |
Dastychová, E; Flasarová, M; Matejková, P; Smajs, D; Valisová, Z; Woznicová, V; Zákoucká, H | 1 |
Göpfrich, H; Kurz, H | 1 |
Mihçiokur, H; Oğuz, M | 1 |
Chmielewska, M; Cieplak, M; Hadzik-Blaszczyk, M; Krupa, R; Kur, Z; Lenartowicz, B; Wardyn, KA; Zycinska, K | 1 |
Gomes, T; Huang, A; Juurlink, DN; Macdonald, EM; Mamdani, MM; Quinn, KL | 1 |
Boland, K; Galambosi, G; Glynn, E | 1 |
Coco, M; Cucuzza, ME; Di Stefano, VA; Garozzo, MT | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Appelbaum, PC; Credito, KL; DeWasse, B; Kosowska-Shick, K; McGhee, P; Pankuch, GA | 1 |
Ki, CS; Kim, IS; Kim, S; Lee, K; Lee, NY; Oh, WS; Peck, KR; Song, JH | 1 |
Baba, S; Billal, DS; Fujihara, K; Hotomi, M; Nishimura, T; Suzuki, K; Yamanaka, N | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Baljer, G; Hanssen-Hübner, C; Hunfeld, KP; Kraiczy, P; Morgenstern, K; Norris, DE | 1 |
Appelbaum, PC; Ednie, LM; Kosowska-Shick, K; McGhee, P | 1 |
Bae, S; Kang, Y; Kim, E; Lee, J; Lee, S; Yu, J | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
3 review(s) available for clarithromycin and cefuroxime
Article | Year |
---|---|
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans | 1994 |
Lyme disease in children and pregnant women.
Topics: Adult; Amoxicillin; Azithromycin; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Clarithromycin; Contraindications; Doxycycline; Female; Humans; Infectious Disease Transmission, Vertical; Lyme Disease; Male; Pregnancy; Pregnancy Complications, Infectious | 2008 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 trial(s) available for clarithromycin and cefuroxime
Article | Year |
---|---|
Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Clarithromycin; Cross-Over Studies; Drug Administration Schedule; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Penicillin Resistance; Serum Bactericidal Test; Streptococcus pneumoniae | 1998 |
Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis.
Topics: Absenteeism; Acute Disease; Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Chi-Square Distribution; Clarithromycin; Confidence Intervals; Female; Humans; Male; Maxillary Sinusitis | 1998 |
Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial | 1999 |
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2002 |
Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Quinolines | 2004 |
Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community -acquired pneumonia in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Child, Preschool; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Female; Humans; Infant; Length of Stay; Male; Pneumonia; Time Factors | 2003 |
[Chronic sinusitis therapy with antibiotics (axetyl cefuroxym, clarithromycin) and steroid (prednisone)].
Topics: Anti-Infective Agents; Cefuroxime; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Prednisone; Sinusitis; Treatment Outcome | 2005 |
Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Topics: Amoxicillin; Anti-Infective Agents; Cefuroxime; Clarithromycin; Female; Follow-Up Studies; Forced Expiratory Volume; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Oximetry; Pulmonary Disease, Chronic Obstructive; Quality of Life; Recurrence; Survival Rate; Time Factors; Treatment Outcome | 2007 |
36 other study(ies) available for clarithromycin and cefuroxime
Article | Year |
---|---|
In vitro susceptibility of recently isolated respiratory tract pathogens to minocycline and comparable antibiotics. A multicentre study.
Topics: Adult; Amoxicillin; Bacteria; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acids; Doxycycline; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Minocycline; Moraxella catarrhalis; Respiratory System; Streptococcus pneumoniae | 1994 |
[Isolation of Chlamydia pneumoniae in atypical pneumonia].
Topics: Adult; Bronchoalveolar Lavage Fluid; Cefuroxime; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; DNA, Bacterial; Fluorescent Antibody Technique; Follow-Up Studies; Humans; Male; Pneumonia, Bacterial; Polymerase Chain Reaction; Recurrence | 1994 |
[Initial empiric treatment of pneumonia and the new antibiotics].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefuroxime; Clarithromycin; Fluoroquinolones; Humans; Pneumonia | 1994 |
Pulmonary Mycobacterium gordonae infection in a two-year-old child: case report.
Topics: Antitubercular Agents; Biopsy; Cefuroxime; Child, Preschool; Clarithromycin; Endodermal Sinus Tumor; Female; Humans; Lung Neoplasms; Mycobacterium Infections; Nontuberculous Mycobacteria; Tomography, X-Ray Computed | 1996 |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Epithelium; Female; Humans; Male; Pulmonary Alveoli | 1996 |
In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefotaxime; Cefuroxime; Child; Child, Preschool; Clarithromycin; Clavulanic Acids; Cross Infection; Haemophilus Infections; Haemophilus influenzae; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Middle Aged | 1996 |
Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Carrier State; Cefaclor; Cefuroxime; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Infant; Microbial Sensitivity Tests; Penicillins; Spain; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment.
Topics: Administration, Oral; Adult; Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Child; Clarithromycin; Clindamycin; Culture Media; Humans; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure | 1997 |
Impredictable susceptibility for cephalosporins in penicillin resistant Streptococcus pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Cephalosporin Resistance; Cephalosporins; Clarithromycin; Drug Therapy, Combination; Female; Humans; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1997 |
Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Clarithromycin; Cohort Studies; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Respiratory Tract Infections; Streptococcus pneumoniae; United States | 1997 |
Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Clarithromycin; Disease Models, Animal; Erythromycin; Fasciitis, Necrotizing; Mice; Mice, Hairless; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pyogenes | 1998 |
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Bacterial Infections; Bronchitis; Cefuroxime; Ciprofloxacin; Clarithromycin; Humans; Time Factors | 1999 |
Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Clarithromycin; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Saudi Arabia; Streptococcus pneumoniae | 2000 |
[Acute exacerbated chronic bronchitis. Antibiotics in comparison].
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Smoking; Time Factors | 2003 |
Pneumonitis after inhalation of mercury vapours.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Cefuroxime; Chelating Agents; Chelation Therapy; Clarithromycin; Humans; Male; Mercury Poisoning; Pneumonia; Radiography; Self-Injurious Behavior; Succimer; Volatilization | 2006 |
Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Estonia; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 2006 |
A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Belgium; Cefuroxime; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Bacterial; Quinolines | 2008 |
Clarithromycin treatment failure due to macrolide resistance in Treponema pallidum in a patient with primary syphilis.
Topics: Anti-Bacterial Agents; Base Sequence; Cefuroxime; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Ribotyping; Syphilis; Treatment Failure; Treponema pallidum; Young Adult | 2010 |
[Epidemiology and morbidity of mycoplasma as causative agent for community-acquired pneumonia in hospitalized children in a Community Hospital in Vienna].
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Austria; C-Reactive Protein; Cefuroxime; Child; Clarithromycin; Community-Acquired Infections; Cross-Sectional Studies; Drug Therapy, Combination; Drug Utilization; Female; Hospitalization; Hospitals, Community; Humans; Incidence; Infusions, Intravenous; Length of Stay; Macrolides; Male; Pneumonia, Mycoplasma; Prospective Studies | 2011 |
Environmental risk assessment of selected pharmaceuticals in Turkey.
Topics: 1-Octanol; Acetaminophen; Adsorption; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Inflammatory Agents, Non-Steroidal; Benzalkonium Compounds; Cefuroxime; Ciprofloxacin; Clarithromycin; Environmental Monitoring; Naproxen; Pharmaceutical Preparations; Risk Assessment; Sewage; Turkey; Water; Water Pollutants, Chemical | 2014 |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acid; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitalization; Host-Pathogen Interactions; Humans; Imipenem; Male; Pneumonia; Retrospective Studies; Treatment Outcome | 2016 |
Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Atrial Fibrillation; Azithromycin; Cardiotonic Agents; Case-Control Studies; Cefuroxime; Clarithromycin; Death, Sudden; Digoxin; Drug Interactions; Erythromycin; Female; Heart Failure; Humans; Macrolides; Male; Ontario; Risk Factors | 2017 |
Resolution of Weight Loss, Systemic Illness, and Fever after Triple Therapy: A Surprising Response to Treatment of Positive Urease Test.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Cefuroxime; Clarithromycin; Doxycycline; Drug Therapy, Combination; Duodenum; Fever; Gastroscopy; Humans; Male; Middle Aged; Predictive Value of Tests; Tomography, X-Ray Computed; Treatment Outcome; Urease; Weight Loss; Whipple Disease | 2021 |
Brucellosis: A Rare Cause of Febrile Neutropenia in a Child.
Topics: Anti-Bacterial Agents; Brucellosis; C-Reactive Protein; Cefuroxime; Child; Child, Preschool; Clarithromycin; Febrile Neutropenia; Female; Fever; Humans; Meropenem; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents.
Topics: Amidohydrolases; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Peptides; Pneumococcal Infections; Species Specificity; Streptococcus pneumoniae; Time Factors | 2007 |
Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea.
Topics: Ampicillin Resistance; beta-Lactamases; Drug Resistance, Bacterial; Genes, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Korea; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Species Specificity | 2007 |
Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan.
Topics: Adolescent; Adult; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Child; Child, Preschool; Female; Gene Frequency; Genotype; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Respiratory Tract Infections | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.
Topics: Anti-Infective Agents; Borrelia burgdorferi; Borrelia burgdorferi Group; Guidelines as Topic; Humans; Lyme Disease; Microbial Sensitivity Tests; Time Factors | 2009 |
Comparative antipneumococcal activities of sulopenem and other drugs.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Lactams; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Streptococcus pneumoniae | 2009 |
Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Ampicillin Resistance; beta-Lactamases; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Penicillin-Binding Proteins; Population Surveillance; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Serotyping; Young Adult | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |